2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery …

G Hindricks, T Potpara, N Dagres, E Arbelo… - European heart …, 2021 - academic.oup.com
MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Clinical pharmacology of oral anticoagulants in patients with kidney disease

N Jain, RF Reilly - Clinical Journal of the American Society of …, 2019 - journals.lww.com
Oral anticoagulants are commonly used drugs in patients with CKD and patients with ESKD
to treat atrial fibrillation to reduce stroke and systemic embolism. Some of these drugs are …

[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

P Kirchhof, S Benussi, D Kotecha… - Polish Heart …, 2016 - journals.viamedica.pl
Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …

[HTML][HTML] Фибрилляция и трепетание предсердий. Клинические рекомендации 2020

МГ Аракелян, ЛА Бокерия, ЕЮ Васильева… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …

[HTML][HTML] 2020 Clinical guidelines for Atrial fibrillation and atrial flutter

MG Arakelyan, LA Bockeria… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
clinical guidelines, atrial fibrillation, ischemic stroke, anticoagulant therapy, vitamin K
antagonists, direct oral anticoagulants, triple antiplatelet therapy, rhythm control, electrical …

[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

F Casselman, A Coca, R De Caterina… - European heart …, 2016 - academia.edu
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial …

CJM Klijn, M Paciaroni, E Berge… - European Stroke …, 2019 - journals.sagepub.com
Patients with ischemic stroke or transient ischemic attack and non-valvular atrial fibrillation
have a high risk of recurrent stroke and other vascular events. The aim of this guideline is to …

Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study

AN Bonde, GYH Lip, AL Kamper, PR Hansen… - Journal of the American …, 2014 - jacc.org
Background: The balance between stroke reduction and increased bleeding associated with
antithrombotic therapy among patients with atrial fibrillation (AF) and chronic kidney disease …

[PDF][PDF] Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS

S Benussi, D Kotecha, A Ahlsson… - Rev Esp …, 2017 - sedeelectronica.comcordoba.com
Se recomienda a los profesionales de la salud que tengan en consideración la presente
guía de la ESC/EACTS en la toma de decisiones clínicas en su ejercicio diario, así como en …

Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation

J Kefer, A Tzikas, X Freixa, S Shakir, S Gafoor… - International journal of …, 2016 - Elsevier
Background Left atrial appendage occlusion (LAAO) using the Amplatzer cardiac plug (ACP)
is a preventive treatment of atrial fibrillation related thromboembolism. Aim To assess the …